|
Axim Biotechnologies Inc (AXIM) |
|
Axim Biotechnologies Inc
AXIM's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Axim Biotechnologies Inc growth rates, revenue grew
by 76.04 % in II. Quarter 2024 from the same quarter a year ago.
Ranking at No. 382
Major Pharmaceutical Preparations industry recorded
growth of revenues by 5.15 %
Axim Biotechnologies Inc net loss decreased from $-4 millions, to $-2 millions in II. Quarter 2024,
• More on AXIM's Growth
|
|
Axim Biotechnologies Inc realized a net loss in trailing twelve months.
Axim Biotechnologies Inc realized cash reduction of $ -0 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 10.78.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.45.
• More on AXIM's Valuation
|
|
|
|
|
Axim Biotechnologies Inc realized net loss in trailing twelve months.
Axim Biotechnologies Inc realized cash outflow of $ -0per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 10.78.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.45.
• More on AXIM's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com